Longtime CEO at Bay Area's OncoMed Steps Down Post author:Sam Post published:January 4, 2018 Post category:BioPharma Board of Directors has initiated search to identify successor. Source: BioSpace You Might Also Like Genentech Shows Off New Mid-Stage DME Data February 11, 2018 This is How 47 Scientists Were Selected for the Chan-Zuckerberg Biohub February 12, 2017 Caladrius Biosciences Closes The Sale Of Its Remaining Interest In PCT To Hitachi Chemical Co., Ltd. For $75 Million May 18, 2017
Caladrius Biosciences Closes The Sale Of Its Remaining Interest In PCT To Hitachi Chemical Co., Ltd. For $75 Million May 18, 2017
